Annual SG&A
$3.08 M
+$527.70 K+20.69%
30 June 2024
Summary:
NanoViricides annual selling, general & administrative expenses is currently $3.08 million, with the most recent change of +$527.70 thousand (+20.69%) on 30 June 2024. During the last 3 years, it has risen by +$449.20 thousand (+17.08%). NNVC annual SG&A is now -19.62% below its all-time high of $3.83 million, reached on 30 June 2016.NNVC Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$1.23 M
+$25.40 K+2.10%
01 September 2024
Summary:
NanoViricides quarterly selling, general & administrative expenses is currently $1.23 million, with the most recent change of +$25.40 thousand (+2.10%) on 01 September 2024. Over the past year, it has increased by +$669.80 thousand (+118.57%). NNVC quarterly SG&A is now -22.48% below its all-time high of $1.59 million, reached on 30 June 2014.NNVC Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$554.06 M
-$9.45 M-1.74%
01 September 2024
Summary:
NanoViricides TTM selling, general & administrative expenses is currently -$554.06 million, with the most recent change of -$9.45 million (-1.74%) on 01 September 2024. Over the past year, it has dropped by -$556.67 million (-21359.30%). NNVC TTM SG&A is now -16437.13% below its all-time high of $4.08 million, reached on 31 March 2016.NNVC TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NNVC Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.7% | +118.6% | -10000.0% |
| 3 y3 years | +17.1% | +139.6% | -10000.0% |
| 5 y5 years | +12.4% | +144.3% | -10000.0% |
NNVC Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +32.2% | at high | +142.2% | -22.1% | at low |
| 5 y | 5 years | -6.7% | +32.2% | -12.3% | +151.9% | -52.4% | at low |
| alltime | all time | -19.6% | +8646.6% | -22.5% | +2743.9% | <-9999.0% | at low |
NanoViricides Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.23 M(+2.1%) | $3.75 M(+21.8%) |
| June 2024 | $3.08 M(+20.7%) | $1.21 M(+74.3%) | $3.08 M(+16.9%) |
| Mar 2024 | - | $693.70 K(+13.6%) | $2.63 M(+3.1%) |
| Dec 2023 | - | $610.90 K(+8.1%) | $2.55 M(-2.0%) |
| Sept 2023 | - | $564.90 K(-26.0%) | $2.61 M(+2.2%) |
| June 2023 | $2.55 M(+9.6%) | $763.40 K(+24.2%) | $2.55 M(+5.9%) |
| Mar 2023 | - | $614.60 K(-7.3%) | $2.41 M(+3.5%) |
| Dec 2022 | - | $663.30 K(+30.1%) | $2.33 M(+0.2%) |
| Sept 2022 | - | $509.70 K(-17.9%) | $2.32 M(-0.2%) |
| June 2022 | $2.33 M(-11.4%) | $621.20 K(+16.6%) | $2.33 M(+6.0%) |
| Mar 2022 | - | $532.80 K(-19.2%) | $2.20 M(-4.8%) |
| Dec 2021 | - | $659.30 K(+27.9%) | $2.31 M(-5.7%) |
| Sept 2021 | - | $515.40 K(+5.1%) | $2.45 M(-6.9%) |
| June 2021 | $2.63 M(-20.3%) | $490.20 K(-23.8%) | $2.63 M(-9.5%) |
| Mar 2021 | - | $643.40 K(-19.4%) | $2.90 M(-20.8%) |
| Dec 2020 | - | $798.70 K(+14.5%) | $3.67 M(+5.1%) |
| Sept 2020 | - | $697.30 K(-8.8%) | $3.49 M(+5.8%) |
| June 2020 | $3.30 M(+20.6%) | $764.90 K(-45.7%) | $3.30 M(+5.9%) |
| Mar 2020 | - | $1.41 M(+126.3%) | $3.12 M(+25.6%) |
| Dec 2019 | - | $622.30 K(+23.1%) | $2.48 M(-3.5%) |
| Sept 2019 | - | $505.50 K(-13.1%) | $2.57 M(-4.5%) |
| June 2019 | $2.74 M(-19.7%) | $581.90 K(-24.7%) | $2.69 M(-5.9%) |
| Mar 2019 | - | $772.60 K(+8.6%) | $2.86 M(-11.0%) |
| Dec 2018 | - | $711.40 K(+13.4%) | $3.22 M(-1.3%) |
| Sept 2018 | - | $627.60 K(-16.5%) | $3.26 M(-4.4%) |
| June 2018 | $3.41 M(+12.4%) | $751.80 K(-33.3%) | $3.41 M(+30.6%) |
| Mar 2018 | - | $1.13 M(+49.4%) | $2.61 M(+2.8%) |
| Dec 2017 | - | $754.10 K(-3.1%) | $2.54 M(-10.0%) |
| Sept 2017 | - | $778.50 K(-1767.0%) | $2.82 M(-6.9%) |
| June 2017 | $3.03 M(-20.8%) | -$46.70 K(-104.4%) | $3.03 M(-23.7%) |
| Mar 2017 | - | $1.06 M(+1.9%) | $3.98 M(+1.9%) |
| Dec 2016 | - | $1.04 M(+4.9%) | $3.90 M(+2.6%) |
| Sept 2016 | - | $988.30 K(+10.5%) | $3.80 M(+1.2%) |
| June 2016 | $3.83 M(+12.6%) | $894.00 K(-8.8%) | $3.76 M(-7.9%) |
| Mar 2016 | - | $980.70 K(+4.6%) | $4.08 M(+11.0%) |
| Dec 2015 | - | $937.80 K(-0.6%) | $3.67 M(+4.3%) |
| Sept 2015 | - | $943.00 K(-22.5%) | $3.52 M(+1.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2015 | $3.40 M(-3.8%) | $1.22 M(+111.2%) | $3.46 M(-9.8%) |
| Mar 2015 | - | $576.20 K(-26.8%) | $3.83 M(-0.8%) |
| Dec 2014 | - | $787.20 K(-10.1%) | $3.86 M(+4.5%) |
| Sept 2014 | - | $876.00 K(-45.0%) | $3.70 M(+4.6%) |
| June 2014 | $3.54 M(+53.9%) | $1.59 M(+162.1%) | $3.54 M(+41.9%) |
| Mar 2014 | - | $607.60 K(-2.1%) | $2.49 M(-8.2%) |
| Dec 2013 | - | $620.90 K(-13.1%) | $2.72 M(+3.3%) |
| Sept 2013 | - | $714.60 K(+30.2%) | $2.63 M(+14.5%) |
| June 2013 | $2.30 M(+26.5%) | $548.90 K(-34.0%) | $2.29 M(+0.6%) |
| Mar 2013 | - | $831.40 K(+55.9%) | $2.28 M(+17.4%) |
| Dec 2012 | - | $533.40 K(+39.9%) | $1.94 M(+12.0%) |
| Sept 2012 | - | $381.20 K(-28.6%) | $1.74 M(-3.7%) |
| June 2012 | $1.82 M(-20.1%) | $534.10 K(+8.1%) | $1.80 M(-7.1%) |
| Mar 2012 | - | $494.10 K(+51.8%) | $1.94 M(-16.0%) |
| Dec 2011 | - | $325.60 K(-27.4%) | $2.31 M(-2.5%) |
| Sept 2011 | - | $448.70 K(-33.3%) | $2.37 M(+3.8%) |
| June 2011 | $2.27 M(+31.0%) | $672.70 K(-22.1%) | $2.28 M(+15.3%) |
| Mar 2011 | - | $863.10 K(+124.6%) | $1.98 M(+3.3%) |
| Dec 2010 | - | $384.30 K(+6.4%) | $1.92 M(+4.8%) |
| Sept 2010 | - | $361.20 K(-2.4%) | $1.83 M(+5.4%) |
| June 2010 | $1.74 M(+59.8%) | $370.10 K(-53.7%) | $1.74 M(+9.2%) |
| Mar 2010 | - | $800.10 K(+169.6%) | $1.59 M(+46.8%) |
| Dec 2009 | - | $296.80 K(+10.7%) | $1.08 M(+7.9%) |
| Sept 2009 | - | $268.10 K(+19.6%) | $1.00 M(-3.3%) |
| June 2009 | $1.09 M(-44.4%) | $224.20 K(-23.5%) | $1.04 M(-23.6%) |
| Mar 2009 | - | $293.20 K(+34.8%) | $1.36 M(-17.1%) |
| Dec 2008 | - | $217.50 K(-28.2%) | $1.64 M(-10.7%) |
| Sept 2008 | - | $302.80 K(-44.3%) | $1.83 M(-6.2%) |
| June 2008 | $1.95 M(-16.9%) | $543.90 K(-5.0%) | $1.95 M(-3.7%) |
| Mar 2008 | - | $572.50 K(+38.8%) | $2.03 M(-5.2%) |
| Dec 2007 | - | $412.60 K(-2.6%) | $2.14 M(-6.5%) |
| Sept 2007 | - | $423.80 K(-31.5%) | $2.29 M(-2.7%) |
| June 2007 | $2.35 M(+38.6%) | $618.80 K(-9.5%) | $2.35 M(+35.7%) |
| Mar 2007 | - | $683.60 K(+21.9%) | $1.73 M(+65.2%) |
| Dec 2006 | - | $560.60 K(+14.9%) | $1.05 M(+114.9%) |
| Sept 2006 | - | $488.10 K | $488.10 K |
| June 2006 | $1.70 M(+4718.2%) | - | - |
| June 2005 | $35.20 K | - | - |
FAQ
- What is NanoViricides annual selling, general & administrative expenses?
- What is the all time high annual SG&A for NanoViricides?
- What is NanoViricides annual SG&A year-on-year change?
- What is NanoViricides quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for NanoViricides?
- What is NanoViricides quarterly SG&A year-on-year change?
- What is NanoViricides TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for NanoViricides?
- What is NanoViricides TTM SG&A year-on-year change?
What is NanoViricides annual selling, general & administrative expenses?
The current annual SG&A of NNVC is $3.08 M
What is the all time high annual SG&A for NanoViricides?
NanoViricides all-time high annual selling, general & administrative expenses is $3.83 M
What is NanoViricides annual SG&A year-on-year change?
Over the past year, NNVC annual selling, general & administrative expenses has changed by +$527.70 K (+20.69%)
What is NanoViricides quarterly selling, general & administrative expenses?
The current quarterly SG&A of NNVC is $1.23 M
What is the all time high quarterly SG&A for NanoViricides?
NanoViricides all-time high quarterly selling, general & administrative expenses is $1.59 M
What is NanoViricides quarterly SG&A year-on-year change?
Over the past year, NNVC quarterly selling, general & administrative expenses has changed by +$669.80 K (+118.57%)
What is NanoViricides TTM selling, general & administrative expenses?
The current TTM SG&A of NNVC is -$554.06 M
What is the all time high TTM SG&A for NanoViricides?
NanoViricides all-time high TTM selling, general & administrative expenses is $4.08 M
What is NanoViricides TTM SG&A year-on-year change?
Over the past year, NNVC TTM selling, general & administrative expenses has changed by -$556.67 M (-21359.30%)